Marc Peeters
Impact in
- Oncology top 0.05%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 308
- Colorectal Cancer Treatments and Studies 148
- Pancreatic and Hepatic Oncology Research 47
- Cancer Immunotherapy and Biomarkers 32
-
- Lung Cancer Treatments and Mutations 58
- Gastric Cancer Management and Outcomes 52
- Co-authors
- Eric Van Cutsem (69 shared papers)Salvatore Siena (32 shared papers)Martin I. Hiele (20 shared papers)Michael Wolf (8 shared papers)Rafael G. Amado (5 shared papers)Jean‐Claude Golinval (11 shared papers)Gaetan Kerschen (11 shared papers)Patrick Pauwels (79 shared papers)
- Journals
- Annals of Oncology (77 papers)Gastroenterology (40 papers)European Journal of Cancer (30 papers)Cancers (20 papers)British Journal of Cancer (19 papers)
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Marc Peeters
681 papers receiving 34.1k citations
Marc Peeters's Hit Papers
Peers
Comparison fields: 5 of 182
- Oncology 15.1k
- Hepatology 3.0k
- Cancer Research 3.7k
- Pulmonary and Respiratory Medicine 5.5k
- Pathology and Forensic Medicine 3.1k
Countries citing papers authored by Marc Peeters
This map shows the geographic impact of Marc Peeters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Peeters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Peeters more than expected).
Fields of papers citing papers by Marc Peeters
This network shows the impact of papers produced by Marc Peeters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Peeters. The network helps show where Marc Peeters may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Peeters, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 696 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 2663 |
| 2 | Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Hit paper breakdown → | 2007 | 1653 |
| 3 | Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer Hit paper breakdown → | 2015 | 1118 |
| 4 | Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study Hit paper breakdown → | 2011 | 856 |
| 5 | Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2010 | 824 |
| 6 | KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab Hit paper breakdown → | 2007 | 728 |
| 7 | Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials Hit paper breakdown → | 2017 | 653 |
| 8 | Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum Hit paper breakdown → | 1991 | 645 |
| 9 | Nonlinear normal modes, Part I: A useful framework for the structural dynamicist Hit paper breakdown → | 2008 | 614 |
| 10 | Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resection Hit paper breakdown → | 1995 | 606 |
| 11 | 2009 | 454 | |
| 12 | Nonlinear normal modes, Part II: Toward a practical computation using numerical continuation techniques Hit paper breakdown → | 2008 | 432 |
| 13 | 2000 | 426 | |
| 14 | 1999 | 419 | |
| 15 | 2014 | 384 | |
| 16 | 2001 | 327 | |
| 17 | 2010 | 308 | |
| 18 | 2009 | 300 | |
| 19 | 2017 | 283 | |
| 20 | 2005 | 269 |
About Marc Peeters
Marc Peeters is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Hepatology and Pathology and Forensic Medicine, having authored 696 papers that have together received 35.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (148 papers), Lung Cancer Treatments and Mutations (58 papers), Gastric Cancer Management and Outcomes (52 papers), Cancer Genomics and Diagnostics (48 papers), Pancreatic and Hepatic Oncology Research (47 papers), Inflammatory Bowel Disease (42 papers), Genetic factors in colorectal cancer (40 papers) and Cancer Immunotherapy and Biomarkers (32 papers). The work is most often cited by research in Oncology (15.1k citations), Hepatology (3.0k citations), Cancer Research (3.7k citations), Pulmonary and Respiratory Medicine (5.5k citations) and Pathology and Forensic Medicine (3.1k citations). Marc Peeters has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Eric Van Cutsem, Salvatore Siena, Martin I. Hiele, Michael Wolf, Rafael G. Amado, Jean‐Claude Golinval, Gaetan Kerschen, Patrick Pauwels, Yves Humblet and Filip Lardon. Their work appears in journals such as Annals of Oncology, Gastroenterology, European Journal of Cancer, Cancers and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.